Ying Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ying Li has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bin Dong
Affiliated Hospital of Hebei University Baoding Hebei People's Republic of China
1 shared publication - Chenyang Wang
College of Electronic Information Engineering and Hebei Key Laboratory of Digital Medical Engineering, Hebei University, Baoding, China
1 shared publication - Cunguang Lou
Hebei University
1 shared publication Gang Li
Department of Gastrointestinal Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei, China
1 shared publicationHengrui Zhang
College of Electronic Information Engineering and Hebei Key Laboratory of Digital Medical Engineering, Hebei University, Baoding, China
1 shared publicationNing Zhou
College of Electronic Information Engineering and Hebei Key Laboratory of Digital Medical Engineering, Hebei University, Baoding, China
1 shared publication
Latest Publications
- 28 August 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 24 (19) , 31095-31103
Detection of Exhaled Methane in Gastrointestinal Disease Population Based on TDLAS
Respiratory detection plays a significant role in the assessment of human health status and in aiding the diagnosis of diseases. This requires the development of fast, economical and non-invasive detection technologies. This research employed tunable diode laser absorption spectroscopy (TDLAS) to analyze exhaled methane (CH 4 ) levels in patients with gastrointestinal diseases. The system achieving a minimum detection limit (MDL) of 42.12 ppbv, and an accuracy of 8.04 ppbv. A total of 451 samples of exhaled CH 4 concentration from gastrointestinal surgery patients were detected, and several gastrointestinal diseases with high average CH 4 concentration were screened out. Support vector machine (SVM) algorithms were used to investigate the relationship between CH 4 levels and specific gastrointestinal diseases. The study achieved a classification accuracy, recall, and precision rate of 100% for ileus, ascending colon cancer (COAD), and cancers with liver metastasis. Meantime, the rate of CH 4 positivity for patients undergone postoperative chemotherapy was observed to be significantly lower than patients with active cancer. However, the presence of CH 4 was not significantly associated with gastrointestinal stromal tumors of the stomach (GIST), stomach cancer (SC), or rectal cancer (READ), indicating the need for a multifaceted diagnostic approach incorporating additional gas markers. In conclusion, CH 4 analysis holds promise as a novel non-invasive diagnostic tool for gastrointestinal diseases, with significant potential for clinical application.
- 28 August 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 24 (19) , 31095-31103
Detection of Exhaled Methane in Gastrointestinal Disease Population Based on TDLAS
Respiratory detection plays a significant role in the assessment of human health status and in aiding the diagnosis of diseases. This requires the development of fast, economical and non-invasive detection technologies. This research employed tunable diode laser absorption spectroscopy (TDLAS) to analyze exhaled methane (CH 4 ) levels in patients with gastrointestinal diseases. The system achieving a minimum detection limit (MDL) of 42.12 ppbv, and an accuracy of 8.04 ppbv. A total of 451 samples of exhaled CH 4 concentration from gastrointestinal surgery patients were detected, and several gastrointestinal diseases with high average CH 4 concentration were screened out. Support vector machine (SVM) algorithms were used to investigate the relationship between CH 4 levels and specific gastrointestinal diseases. The study achieved a classification accuracy, recall, and precision rate of 100% for ileus, ascending colon cancer (COAD), and cancers with liver metastasis. Meantime, the rate of CH 4 positivity for patients undergone postoperative chemotherapy was observed to be significantly lower than patients with active cancer. However, the presence of CH 4 was not significantly associated with gastrointestinal stromal tumors of the stomach (GIST), stomach cancer (SC), or rectal cancer (READ), indicating the need for a multifaceted diagnostic approach incorporating additional gas markers. In conclusion, CH 4 analysis holds promise as a novel non-invasive diagnostic tool for gastrointestinal diseases, with significant potential for clinical application.